HEPARIN CHEMISTRY REGULATING LIVER GENE EXPRESSION
HEPARIN CHEMISTRY REGULATING LIVER GENE EXPRESSION
批准号:
2143661
负责人:
LOLA M REID
金额:
$16.37万
依托单位国家:
美国
项目类别:
财政年份:
1992
资助国家:
美国
项目状态:
已结题
起止时间:
1992-05-01 至 1995-04-30
关键词:
RNA biosynthesis acidity /alkalinity biological signal transduction calcium flux chemical structure function electrophysiology gap junctions gene expression genetic regulation heparin hormone regulation /control mechanism insulin receptor insulinlike growth factor liver cells liver function mass tissue /cell culture messenger RNA mucopolysaccharides peptide hormone
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Expression of liver-specific genes, especially their mRNA synthesis, was
found dependent upon cooperative effects of peptide hormones and heparins
(HPs). Comparison of more than 40+ species of intact, native
glycosaminoglycans (GAGs) and PGs indicates that only HPs or PGS with HP-
like GAG chains, can cooperate with peptide hormones to regulate mRNA
synthesis of tissue-specific genes. By contrast, heparin sulfates (HSs),
at all concentrations and from all sources, proved inactive or even
inhibitory. Posttranscriptional effects were observed with all tested PGs,
and of the GAGs, with all species of HPs and weakly with dermantan sulfates
(DSs). The rank order of potency of the PGs with respect to
posttranscriptional effects was HP-PGs>>HS-PGs>>>DS-PGs>>chondroitin
sulfate-PG (CS-PG) and of the active GAGs, HPs>>>>DSs.
We propose to complete a structure-function analysis, ongoing, to define
the chemistry of active PGs and GAGs enabling them to regulate gene
expression. Our completed studies allow us to focus on HPs, the
biologically active components of HP-PGs, the most active species of PG
able to regulate gene expression in liver cells. HSs are closely related
chemically, are inactive, and will be used as negative controls. The
biological assays, all documented to be HP sensitive, will be: [1)
morphological assays to detect nuclear shape changes;] 2) molecular
hybridization assays for mRNA synthesis and abundance of insulin-responsive
genes; and 3) electrophysiological assays for gap junctions. Cells will be
treated with a test HP or HP fraction when in serum-free medium
supplemented only with completely defined and purified hormones or growth
factors, the composition and concentrations tailored for each gene. The
format of the analysis is to: 1) complete the screens of HPs and of
polyanions with HP-like activity (e.g. suramin) allowing us to identify
especially active species; 2) dissect the most active ones for
contributions of molecular weight (chain length), charge density, degree
and form of sulfation, and extent of anticoagulant activity; [3) chemically
and structurally analyze the most active fractions of the most active HPs
and polyanions; 4) deduce from the chemical analysis what the active
fractions have in common and prepare modified versions accordingly; 5)
assess the biological activity of the modified versions and 6) repeat 3-5
until the active saccharide sequences (s) are identified.]
The most active HP saccharide(s) identified will be used to initiate
studies on the signal transduction mechanism(s) involved in HP/insulin's
regulation of gene expression. We will focus initially on studies of
calcium and intracellular pH, since our prior studies indicated that
membrane-permanent analogues of one known second messenger, cAMP, were
unable to synergize with HPs in the regulation of transcription rates for
any liver-specific gene assayed. [We will also assess whether HPs modify
insulin receptor levels or the binding affinity of insulin for its own
receptor or for the receptors for IGF I or II.]
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
CORE--ADVANCED CELL TECHNOLOGIES
-
批准号:6316584
-
项目类别:
-
资助金额:$16.67万
-
财政年份:2000
-
负责人:LOLA M REID
-
依托单位:
CORE--ADVANCED CELL TECHNOLOGIES
-
批准号:6410310
-
项目类别:
-
资助金额:$16.67万
-
财政年份:2000
-
负责人:LOLA M REID
-
依托单位:
CORE--CELL CULTURE FACILITY
-
批准号:6105286
-
项目类别:
-
资助金额:$16.67万
-
财政年份:1999
-
负责人:LOLA M REID
-
依托单位:
BIOARTIFICIAL LIVERS FROM HEPATIC PROGENITOR CELLS
-
批准号:2906056
-
项目类别:
-
资助金额:$29.66万
-
财政年份:1998
-
负责人:LOLA M REID
-
依托单位:
BIOARTIFICIAL LIVERS FROM HEPATIC PROGENITOR CELLS
-
批准号:6381395
-
项目类别:
-
资助金额:$31.47万
-
财政年份:1998
-
负责人:LOLA M REID
-
依托单位:
BIOARTIFICIAL LIVERS FROM HEPATIC PROGENITOR CELLS
-
批准号:6177720
-
项目类别:
-
资助金额:$30.55万
-
财政年份:1998
-
负责人:LOLA M REID
-
依托单位:
BIOARTIFICIAL LIVERS FROM HEPATIC PROGENITOR CELLS
-
批准号:2624509
-
项目类别:
-
资助金额:$28.8万
-
财政年份:1998
-
负责人:LOLA M REID
-
依托单位:
CORE--CELL CULTURE FACILITY
-
批准号:6270604
-
项目类别:
-
资助金额:$15.62万
-
财政年份:1997
-
负责人:LOLA M REID
-
依托单位:
BIOARTIFICIAL LIVERS FROM HEPATIC PROGENITOR CELLS
-
批准号:2654560
-
项目类别:
-
资助金额:$10.0万
-
财政年份:1997
-
负责人:LOLA M REID
-
依托单位:
CORE--CELL CULTURE FACILITY
-
批准号:6238869
-
项目类别:
-
资助金额:$11.72万
-
财政年份:1996
-
负责人:LOLA M REID
-
依托单位:
HEPARIN CHEMISTRY REGULATING LIVER GENE EXPRESSION
-
批准号:2143663
-
项目类别:
-
资助金额:$15.42万
-
财政年份:1992
-
负责人:LOLA M REID
-
依托单位:
HEPARIN CHEMISTRY REGULATING LIVER GENE EXPRESSION
-
批准号:2143662
-
项目类别:
-
资助金额:$14.83万
-
财政年份:1992
-
负责人:LOLA M REID
-
依托单位:
HEPARIN CHEMISTRY REGULATING LIVER GENE EXPRESSION
-
批准号:3245800
-
项目类别:
-
资助金额:$17.43万
-
财政年份:1992
-
负责人:LOLA M REID
-
依托单位:
MATRIX, HORMONES, AND DIFFERENTIATION IN MAMMALIAN CELLS
-
批准号:3071447
-
项目类别:
-
资助金额:$5.52万
-
财政年份:1983
-
负责人:LOLA M REID
-
依托单位:
MATRIX, HORMONES, AND DIFFERENTIATION IN MAMMALIAN CELLS
-
批准号:3071445
-
项目类别:
-
资助金额:$5.54万
-
财政年份:1983
-
负责人:LOLA M REID
-
依托单位:
MATRIX, HORMONES, AND DIFFERENTIATION IN MAMMALIAN CELLS
-
批准号:3071446
-
项目类别:
-
资助金额:$5.57万
-
财政年份:1983
-
负责人:LOLA M REID
-
依托单位:
REGULATION OF CELLS BY MATRIX AND HORMONES
-
批准号:3169069
-
项目类别:
-
资助金额:$20.24万
-
财政年份:1981
-
负责人:LOLA M REID
-
依托单位:
REGULATION OF CELLS BY MATRIX AND HORMONES
-
批准号:3169070
-
项目类别:
-
资助金额:$20.69万
-
财政年份:1981
-
负责人:LOLA M REID
-
依托单位:
CELL CULTURE CORE FACILITY
-
批准号:4689137
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:LOLA M REID
-
依托单位:
HOST DEFENSE MECHANISMS CONTROLLING TUMOR FORMATION AND METASTASES--PILOT
-
批准号:4690376
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:LOLA M REID
-
依托单位: